The Vascular Quality Initiative assessment of the Bard Lifestent for the treatment of popliteal artery occlusive disease

The Bard LifeStent self-expanding stent is approved for the treatment of occlusive disease involving the superficial femoral artery and proximal popliteal artery. We conducted a post-market trial of treatment of the popliteal artery above and below the knee (P1, P2, and P3 segments) within the Society for Vascular Surgery Vascular Quality Initiative (VQI) Peripheral Vascular Intervention registry.

Source: Journal of Vascular Surgery - August 28, 2023 Category: Surgery Authors: Daniel J. Bertges, Jens Eldrup-Jorgensen, Mark K. Eskandari, Allen Hamdan, Carlos Mena-Hurtado, Mark Mewissen, Taylor Smith, Edward Woo, Jack L. Cronenwett, Society for Vascular Surgery Vascular Quality Initiative Source Type: research